UNICHEM LABORATORIES
|
The Current P/E Ratio of UNICHEM LABORATORIES is 27.06.
Share Price | ₹502.9 | Sep 19,2025 |
Market Cap | ₹3,540.1 Cr | |
Earnings-TTM | ₹130.8 Cr | TTM-Consolidated Results |
Price/Earnings | 27.06x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of UNICHEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,540.1 Cr] as on Sep 19,2025
(/) Earnings [ ₹130.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 27.06x ]
Thus, for UNICHEM LABORATORIES , the investors are currently willing to pay 27.06 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of UNICHEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of UNICHEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of UNICHEM LABORATORIES
PE Ratio Performance Analysis for UNICHEM LABORATORIES
- UNICHEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 30.87x.
- UNICHEM LABORATORIES 's operated at median p/e ratio of 35.47x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, UNICHEM LABORATORIES 's p/e ratio peaked in Mar2021 at 63.44x.
- UNICHEM LABORATORIES 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does UNICHEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
UNICHEM LABORATORIES | 130.84 | 27.06 | 3,540.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.16 | 397,342.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 71.36 | 164,555.0 |
CIPLA LTD | 5,406.81 | 23.54 | 127,259.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.39 | 122,898.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.28 | 110,394.0 |
MANKIND PHARMA LTD | 1,905.51 | 57.64 | 109,835.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.50 | 104,346.0 |
LUPIN LTD | 3,722.18 | 25.23 | 93,917.9 |
AUROBINDO PHARMA LTD | 3,417.93 | 19.00 | 64,953.9 |
ABBOTT INDIA LTD | 1,452.29 | 44.33 | 64,384.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs UNICHEM LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.00x |
Max industry PE | 71.36x |
Median industry PE | 27.06x |
Average industry PE | 37.23x |
You may also like the below Video Courses